CAI Q2 2014 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q2 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$55M+4.4% YoY

Gross Profit

$36M65.5% margin

Operating Income

$23M41.5% margin

Net Income

$13M24.3% margin

EPS (Diluted)

$0.60

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

$37M

Free Cash Flow

-$48M

Stock-Based Comp.

$433,000

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$1.3B

Stockholders' Equity

$424M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$55M	$53M	+4.4%
Gross Profit	$36M	$37M	-1.2%
Operating Income	$23M	$26M	-12.1%
Net Income	$13M	$17M	-20.6%